Company profile

Imbio, Inc.

Imbio, Inc. has 3 AI-enabled medical devices on the FDA list. The first decision was on June 13, 2023 and the most recent on December 19, 2024 (IQ-UIP). Its most common review panel is Radiology (3 devices).

3AI devices
2023First decision
2024Latest decision
1Specialties

Per year

2023: 12024: 2
20232024
Imbio, Inc. AI devices per year: 2023 1, 2024 2

By specialty

  • Radiology3

Related guides

Timeline

  1. IQ-UIP · Radiology · QWO
  2. Imbio PHA (4.0.0) · Radiology · QIH
  3. CAC Software · Radiology · JAK